Variable | Adherent to surveillance guidelines | Odds ratio | P value* |
---|---|---|---|
(95% CI) | |||
Experimental group | |||
Control | 55 (26%) | REF | |
Intervention | 66 (29%) | 1.01 (0.64–1.6) | 0.954 |
Age | |||
under 50 | 3 (14%) | 0.44 (0.11–1.83) | |
50–59 | 14 (17%) | 0.56 (0.24–1.34) | |
60–69 | 31 (22%) | 0.77 (0.42–1.4) | |
70–79 | 39 (31%) | REF | |
over 80 | 34 (47%) | 2 (1.05–3.98) | 0.049 |
Sex | |||
Male | 68 (29%) | REF | |
Female | 53 (26%) | 0.91 (0.56–1.47) | 0.697 |
Highest level of education | |||
University or vocational training | 34 (22%) | REF | |
Secondary school completed | 23 (34%) | 1.6 (0.8–3.12) | |
Secondary school not completed | 64 (29%) | 1.03 (0.6–1.77) | 0.367 |
Relationship status | |||
Single | 36 (33%) | REF | |
Married/defacto | 85 (26%) | 1.01 (0.58–1.76) | 0.97 |
Employment status | |||
Not employed | 95 (33%) | REF | |
Employed | 26 (17%) | 0.58 (0.3–1.12) | 0.107 |
Australian born | |||
No | 24 (26%) | REF | |
Yes | 97 (28%) | 1.2 (0.68–2.14) | 0.519 |
Location or residence | |||
Rural | 52 (34%) | REF | |
Urban | 69 (24%) | 0.65 (0.4–1.05) | 0.081 |
Private health insurance | |||
No | 44 (34%) | REF | |
Yes | 77 (25%) | 0.81 (0.49–1.33) | 0.406 |
Disease stage | |||
TNM Stage I | 45 (31%) | REF | |
TNM Stage II | 44 (27%) | 0.67 (0.39–1.16) | |
TNM Stage III | 32 (24%) | 0.76 (0.43–1.36) | 0.349 |
Cancer site | |||
Right sided | 45 (24%) | REF | |
left-sided | 76 (30%) | 1.8 (1.13–3.02) | 0.014 |
Saw specialist for follow up care | |||
No | 14 (61%) | REF | |
Yes | 107 (26%) | 0.35 (0.14–0.91) | 0.031 |